Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2017-01-27T13:32:41Z No. of bitstreams: 1 FabianaLimaBezerra_TESE.pdf: 4985146 bytes, checksum: ce1c1005e6775f052912c875b1d39910 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2017-01-31T13:32:42Z (GMT) No. of bitstreams: 1 FabianaLimaBezerra_TESE.pdf: 4985146 bytes, checksum: ce1c1005e6775f052912c875b1d39910 (MD5) / Made available in DSpace on 2017-01-31T13:32:42Z (GMT). No. of bitstreams: 1 FabianaLimaBezerra_TESE.pdf: 4985146 bytes, checksum: ce1c1005e6775f052912c875b1d39910 (MD5) Previous issue date: 2016-06-14 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq) / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / A dengue ? a mais importante arbovirose que afeta o homem e constitui-se em um grave problema de sa?de p?blica. A doen?a ? end?mica em regi?es tropicais e subtropicais, abrangendo mais de 100 pa?ses, correspondendo ? metade da popula??o mundial. As epidemias s?o recorrentes e estima-se que os v?rus da dengue causem 390 milh?es de infec??es a cada ano, sendo uma importante causa de morbidade. Apesar desse cen?rio, atualmente, ainda n?o se disp?e de um antiviral contra a dengue. Neste contexto, diversos estudos relatam a atividade antiviral dos polissacar?deos sulfatados obtidos das algas marinhas contra v?rus envelopados, cuja a??o est? associada ? interfer?ncia nas etapas iniciais do processo de infec??o viral. Neste estudo, avaliou-se a potencial atividade antiviral de extratos brutos ricos em polissacar?deos sulfatados obtidos das algas marrons Dictyota menstrualis (EBDMens) e Dictyota mertensii (EBDM) e das algas verdes Codium isthmocladum (EBCI) e Caulerpa sertularioides (EBCS) contra o v?rus dengue 2 (DENV-2), em linhagem de c?lulas Vero, usando diferentes estrat?gias metodol?gicas (tratamento simult?neo, tratamento p?s-infec??o, pr?-tratamento da c?lula, pr?tratamento do v?rus, adsor??o, p?s-adsor??o e penetra??o). A citotoxicidade dos extratos foi analisada pelo ensaio de redu??o do MTT. O estudo da atividade antiviral foi determinado pela quantifica??o do n?mero de c?pias do RNA viral por RT-qPCR ap?s 120 h de infec??o. Nenhum extrato exibiu toxicidade para as c?lulas Vero no ensaio de redu??o do MTT na concentra??o de 100 ?g/mL. Todos os extratos exibiram atividade antiviral quando adicionados durante os primeiros 90 minutos de infec??o, demonstrando redu??o significativa no n?mero de c?pias do RNA viral ap?s 120 horas. Os extratos EBDMens e EBDM foram mais eficazes nos ensaios de pr?-tratamento da c?lula e do v?rus, e o primeiro exerceu atividade antiviral superior ao EBDM durante a adsor??o viral. Os extratos EBCI e EBCS apresentaram atividade antiviral semelhante no ensaio de pr?-tratamento da c?lula. O EBCI foi mais eficaz na redu??o da adsor??o do DENV-2 em c?lulas Vero. Por?m, o EBCS se mostrou mais eficiente nos ensaios de pr?-tratamento do v?rus e penetra??o. Dentre os extratos avaliados, o EBCS parece ser o mais efetivo no combate ao DENV-2. Estes resultados revelam o potencial desses extratos ricos em polissacar?deos sulfatados como compostos com a??o antiviral, sugerindo que eles atuam nos est?gios iniciais da infec??o por DENV-2. / Dengue is considered the most important human arboviruses, and is a serious public health problem. This disease is endemic in tropical and subtropical regions, reaching more than 100 countries, which means the half of world population, and those epidemies have been appellant. It is estimated that Dengue virus could cause 390 millions of infections each year, and is an important cause of morbidity. Although this scenario, actually doesn?t exist a dengue antivirals still. Sorts of studies have showed antivirus activity of seaweed sulfated polysaccharides against enveloped viruses, which action seems to be associated to initials steps of infection process. In this study, was evaluated the potential antiviral activity of crude extracts rich in sulfated polysaccharides obtained from the brown algae Dyctiota menstrualis (EBDMens) and Dyctiota mertensii (EBDM), and green algae Codium isthmocladium (EBCl) and Caulerpa sertularioides (EBCS), tested against Dengue virus 2 (DENV-2) in Vero cell line, by using different methodological strategies (simultaneous treatment, post-infection treatment, cell pre-treatment, virus pre-treatment, adsorption, post-adsorption and penetration). The extracts cytotoxicity was evaluated by MTT reduction assay. The study of antiviral activity was determinated by quantifying viral RNA load using RT-qPCR, after 120 hours of infection. None extract has showed toxicity against Vero Cells in MTT reduction assay with 100 ?g/mL concentration. All extracts have shown antiviral activity when added during the first 90 minutes of infection, and a significant reduction of viral RNA number of copies after 120 hours. The EBDMens and EBDM extracts were more efficient to cell and virus pretreatment assays, and the first has showed higher antiviral activity than EBDM during viral adsorption. The EBCI and EBCS extracts have presented antiviral activity very similar in cell pre-treatment assay. EBCI was more efficient in the reduction of DENV-2 adsorption in Vero cell. However, EBCS has showed more efficient in cell pre-treatment and penetration assays. Between the extracts evaluated, EBCS seems to be more effective against DENV-2. These results have showed potential action of extracts rich in sulfated polysaccharides with antivirus activity, suggesting that they act in the initials steps of infection process of DENV-2.